Pure Global

FlexTest transmission type blood pressure/blood glucose/cholesterol monitoring system - Taiwan Registration 21887959c19f1a3b22c8d37825ca0c95

Access comprehensive regulatory information for FlexTest transmission type blood pressure/blood glucose/cholesterol monitoring system in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 21887959c19f1a3b22c8d37825ca0c95 and manufactured by BIOPTIK TECHNOLOGY, INC.. The authorized representative in Taiwan is BIOPTIK TECHNOLOGY, INC..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
21887959c19f1a3b22c8d37825ca0c95
Registration Details
Taiwan FDA Registration: 21887959c19f1a3b22c8d37825ca0c95
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

FlexTest transmission type blood pressure/blood glucose/cholesterol monitoring system
TW: ๆ˜“็ซ‹ๆธฌ ๅ‚ณ่ผธๅž‹ ่ก€ๅฃ“/่ก€็ณ–/่†ฝๅ›บ้†‡ ็›ฃๆธฌ็ณป็ตฑ
Risk Class 2

Registration Details

21887959c19f1a3b22c8d37825ca0c95

Company Information

Taiwan, Province of China

Product Details

This product provides blood pressure measurement function, including arterial diastolic blood pressure and systolic blood pressure, and can also quantitatively detect blood glucose and cholesterol content in fingertip microvascular whole blood. Blood pressure measurement is suitable for adults over 16 years old, blood glucose and cholesterol measurement is not suitable for newborn testing.

A more 1.50.55.00.a.s. It's not a one-way trip.

E.1130 Non-invasive blood pressure measurement systems;; A.1345 Glucose Test System;; A.1175 Cholesterol (Total) Testing System

Domestic

Dates and Status

May 16, 2017

May 16, 2027